Thomas W. Bell

Immunology and MicrobiologyChemistryMaterials ScienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “The signal peptide as a new target for drug design”.

The signal peptide as a new target for drug design

Bioorganic & Medicinal Chemistry Letters(2020)10.1016/j.bmcl.2020.127115

N/A

0DataRank · unranked

49 citations

Thomas W. Bell, Liezel A. Lumangtad

Syntheses and anti-HIV and human cluster of differentiation 4 (CD4) down-modulating potencies of pyridine-fused cyclotriazadisulfonamide (CADA) compounds

Bioorganic & Medicinal Chemistry(2020)10.1016/j.bmc.2020.115816

N/A

0DataRank · unranked

14 citations

Elisa Claeys, Sunil Hamal, Amarawan Intasiri, Courtney Basrai, Expédite Yen‐Pon +4 more

Isoform selectivities of novel 4-hydroxycoumarin imines as inhibitors of myosin II

European Journal of Medicinal Chemistry(2022)10.1016/j.ejmech.2022.115008

N/A

0DataRank · unranked

5 citations

Jhonnathan Brawley, Kate C Bordenave, Ryan K Olsen, Amarawan Intasiri, Christine Cremo +2 more

Role of Sec61α2 Translocon in Insulin Biosynthesis

Diabetes(2024)10.2337/db24-0115

N/A

0DataRank · unranked

6 citations

Thomas W. Bell, Truc Le, Ivy Yan Zhao, Emily M. Walker, Yiqin Wang +8 more

Inhibition of TSH Receptor Expression by a Cyclotriazadisulfonamide as a Potential Treatment of Graves Hyperthyroidism

Endocrinology(2025)10.1210/endocr/bqaf037

N/A

0DataRank · unranked

3 citations

Susanne Neumann, Xiangliang Sui, Jay Scott Templin, Topprasad Kapri, Violeta G. Demillo +5 more